Difficulty: Medium
Average Score: 86%
Practice
Your patient with relapsed high-risk neuroblastoma returns to your care after travelling to an outside institution for 131I-MIBG therapy. In the weeks following 131I-MIBG therapy, what adverse events directly attributable to this therapy will the patient most likely encounter?
Correct answer
A
Rationale
Myelosuppression is a common side effect following 131I-MIBG therapy due to bone marrow suppression.